Active ingredient /generic name | Brand name | Indication | ZIN | NICE | CADTH | PBAC/MSAC |
---|---|---|---|---|---|---|
Dabrafenib and trametinib | Tafinlar and mekenist | Melanoma | 1 | 1 | 1 | 1 |
Ipilimumab and nivolumab | Yervoy and Opdivo | Renal cell carcinoma | 1 | 1 | 1 | 1 |
Venetoclax and retuximab | Venclyxto and generic | Chronic lymphocytic leukaemia | 1 | 1 | 1 | 1 |
Durvalumab | Imfinzi | Non-small cell lung cancer | 1 | 1 | 1 | 1 |
Abemaciclib | Verzenios | Breast cancer | 1 | 2 | 1 | 1 |
Axicabtagene ciloleucel | Yeskarta | Large B-cell lymphoma | 1 | 1 | 1 | 1 |
Tisagenlecleucel | Kymriah | Large B-cell lymphoma/Acute lymphocytic leukaemia | 2 | 2 | 1 | 2 |
Dinutuximab beta | Qarziba | Neuroblastoma | 1 | 1 | 1 | 0 |
Osimertinib | Tagrisso | Non-small cell lung cancer | 1 | 1 | 1 | 1 |
Atezolizumab | Tecentriq | Non-small cell lung cancer | 1 | 1 | 1 | 1 |
Ribociclib | Kisqali | Breast cancer | 1 | 1 | 1 | 1 |
Daratumumab | Darzalex | Myeloma | 1 | 1 | 1 | 1 |
Cetuximab | Erbitux | Colorectal cancer | 1 | 1 | 1 | 1 |
Ibrutinib | Imbruvica | Lymphocytic leukaemia | 1 | 1 | 2 | 1 |
Palbociclib | Ibrance | Breast cancer | 1 | 2 | 2 | 1 |